Home | My Account | Online Store | Contact & Demand | Press Room | About Us | FAQs
Home
Buy & Subscribe
Special Features
Products & Services
Online Store
Products by category
Products by publisher
Product lines
News Channels
Biotechnology
Therapeutic Areas
Business
RSS Feeds
Free RSS News
Get the latest news direct
to your desktop
feed image

Search in our News Channels

  

Search in our Online Store
DNA, RNA & Cells
Filter     Order     Display # 
Date Item Title
28 Aug 2007 Geron Scientists and collaborators demonstrate human embryonic stem cell-derived cardiomyocytes improve heart function when transplanted after myocardial infarction
28 Aug 2007 Diamyd updates gene therapy program and outlines plans for Phase I clinical trial for treatment of cancer pain
17 Aug 2007 Inovio Biomedical partner Tripep receives approval to initiate Phase I/II study of novel vaccine for hepatitis C virus
16 Aug 2007 Bioniche provides update on refractory bladder cancer trial
13 Aug 2007 Ophthotech raises $36 million; in-licenses two compounds for macular degeneration
13 Aug 2007 Pervasis Therapeutics Successfully Completes Enrollment for Vascugel(TM) Phase II Clinical Trials
11 Aug 2007 Proteo, Inc./Proteo Biotech AG - Minapharm/Rhein Minapharm Biogenetics SAE: Proteo Biotech, Germany and Minapharm, Egypt enter into development and license agreement for Elafin
10 Aug 2007 Tissera reports significant milestone achievement in its large animal diabetic model studies.
07 Aug 2007 Antisoma starts phase II trial of AS1411 in acute myeloid leukaemia
03 Aug 2007 Quark Pharmaceuticals, Inc. Presented Positive Preclinical Results of Systemic RNAi Compound for Acute Renal Failure (ARF)
02 Aug 2007 OncoGenex Initiates Phase I Clinical Trial of OGX-427 in Cancer
01 Aug 2007 OncoGenex and Isis Report Encouraging Interim Phase II Data in Advanced Prostate Cancer, Affirm Phase III Clinical Trial Plans
31 Jul 2007 Alnylam and Medtronic Advance Collaboration on Drug-Device Combinations with RNAi Therapeutics for CNS Diseases
25 Jul 2007 Targeted Genetics' Inflammatory Arthritis Phase I/II Trial Placed on Clinical Hold
24 Jul 2007 Oncolytics Biotech Inc. Starts Patient Enrolment in U.K. Combination REOLYSIN(R)/Docetaxel trial
24 Jul 2007 Pluristem's PLX Cells Show Promise in Treating Limb Ischemia
21 Jul 2007 Expression Genetics, Inc. Announces Further Clinical Advancement of its Gene-Based IL-12 Therapy Co-administered with Standard Chemotherapy for Treatment of Ovarian Cancer
20 Jul 2007 EMEA Indicates that Genasense(R) Approval in Melanoma Will Require Confirmatory Clinical Trial
19 Jul 2007 FDA Grants Fast Track Designation to Cardium's Phase 3 Angiogenic Gene Therapy for Heart Disease
12 Jul 2007 Opko Health Initiates Phase 3 Trial of Bevasiranib for the Treatment of AMD
10 Jul 2007 Geron initiates clinical trial of Telomerase inhibitor drug in combination with Paclitaxel and ccarboplatin in patients with non-small cell lung cancer
08 Jul 2007 Cancer-fighting virus shows promise in early clinical trial
07 Jul 2007 siRNA collaboration with AstraZeneca
03 Jul 2007 Beike Biotechnology Study Suggests Adult Stem Cells Show Promise for Peripheral Vascular Disease
30 Jun 2007 Medistem Laboratories Announces Positive Preclinical Results for MDS-786 Candidate
29 Jun 2007 Titan Annnounces Completion of Patient Enrollment in Randomized Phase IIb Clinical Study of Spheramine(R) In Parkinson’s Disease
28 Jun 2007 Gentium's Defibrotide Seen as Active in Multiple Myeloma
28 Jun 2007 First Patient Treated in Aastrom Adult Stem Cell Trial for Critical Limb Ischemia
26 Jun 2007 Alnylam Initiates Phase II Clinical Trial to Evaluate Safety and Anti-viral Efficacy of ALN-RSV01 in the Treatment of Respiratory Syncytial Virus (RSV) Infection
25 Jun 2007 ADA Conference Presentations Highlight Isis' Metabolic Disease Program Research Activities
23 Jun 2007 Sangamo BioSciences Announces Presentation of Phase 1 ZFP Therapeutic Data at American Diabetes Association Meeting
22 Jun 2007 Oncolys BioPharma and Tacere Therapeutics form strategic alliance to develop RNAi Hepatitis C drug
22 Jun 2007 Ceregene and Genzyme Announce Partnership for the Development and Commercialization of CERE-120 for Parkinson's Disease
22 Jun 2007 Neurologix Announces Publication of Landmark Gene Therapy Study Demonstrating Safety and Statistically Significant Improvement in Patients With Advanced Parkinson's Disease
20 Jun 2007 Research documents scalable production, survival following engraftment and positive impact on cardiac function in infarcted rats for geron's human embryonic stem cell-based therapeutic for heart failure
20 Jun 2007 Lorus Therapeutics announces the initiation of a clinical trial of GTI-2040 in acute leukemia and myelodysplastic syndrome
19 Jun 2007 Vical Licensee AnGes MG Announces Positive Results of Phase 3 Angiogenesis Trial in Japan
19 Jun 2007 StemCells, Inc. Announces Important Milestone in Batten Disease Clinical Trial
15 Jun 2007 Targeted Genetics Reports Inflammatory Arthritis Clinical Data at European Rheumatology Conference
15 Jun 2007 Diabetes Patient Successfully Transplanted in World-first DiabeCell(R) Trial
12 Jun 2007 Merck Signs Strategic Alliance With Archemix
12 Jun 2007 Archemix and Takeda to Enter into Collaboration for
09 Jun 2007 Archemix Announces Completion of Phase 1 Trial of ARC1779
07 Jun 2007 Sangamo BioSciences Presents First ZFP Therapeutic Data Demonstrating in Vivo Protection Against HIV
07 Jun 2007 Santaris Pharma presents positive clinical data on SPC2996 in Chronic Lymphocytic Leukaemia
03 Jun 2007 Study Presented at ASCO Shows Encouraging Preliminary Results for Phase II
02 Jun 2007 Introgen Reports Promising Phase 1/2 Clinical Results With INGN 241 in Patients With Advanced Solid Tumors
02 Jun 2007 Prophylactic Treatment with Defibrotide in Post Transplant Patients May Reduce Incidence of Death in VOD
01 Jun 2007 AMT Presents Positive Results of Phase I/II Study with Lead Product at Annual Meeting of American Society of Gene Therapy
31 May 2007 Introgen's ADVEXIN Demonstrates Clinical Benefit in Inherited Cancer
 
<< Start < Prev 1 2 3 4 5 6 7 8 9 10 Next > End >>
Results 201 - 250 of 591

PipelineReview.com is powered by La Merie Business Intelligence La Merie Business Intelligence

For immediate assistance, please call us during business hours: Mon-Fri 09:00am - 18:30pm; GMT+01

La Merie S.L | Passatge Jordi Ferran, 20 | E-08028 Barcelona | T +34 93 342 91 97 | F +34 93 342 91 98 | Email info@lamerie.com | Internet www.lamerie.com
All contents © by La Merie S. L

Competitor Analysis Series

Thrombopoiesis-Stimulating Agents (TPO)

Order Now

Brief Report Series

CD40 and CD40L (CD154) Agonists & Antagonists

Order Now

Subscribe La Merie Biologics